Tissue Regenix Group (TRX)

 

TRX Share PerformanceMore

52 week high19.500 21/02/17
52 week low5.500 08/12/17
52 week change -11.200 (-59.73%)
4 week volume1,048,632 25/01/18
price7.550
price date1519136754
close8.000

Latest NewsMore

Issue of Equity

RNS Number: 7443D Tissue Regenix Group PLC 02 February 2018 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 02 February 2018 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 658,081 ordinary shares of 0.5p each in the Co...

Issue of Equity

RNS Number: 1940A Tissue Regenix Group PLC 22 December 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 22 December 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 8,307,608 ordinary shares of 0.5p each in the...

Tissue Regenix CFO resigns

Tissue Regenix Group said chief financial officer Paul Devlin has resigned. The company said it would commence a search...

Directorate Change

RNS Number: 0705Y Tissue Regenix Group PLC 01 December 2017 Tissue Regenix Group plc Directorate Change Leeds, 01 December 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, announces that the Board has accepted the resignation of Paul Devlin, CFO. The Board will commence a process to...

Issue of Equity

RNS Number: 0678Y Tissue Regenix Group PLC 01 December 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 01 December 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 552,337 ordinary shares of 0.5p each in the C...

Tissue Regenix appoints CEO

Tissue Regenix, a regenerative medical devices company, has appointed Steve Couldwell as chief executive officer of the gr...

Appointment of CEO

RNS Number: 3338V Tissue Regenix Group PLC 02 November 2017 Tissue Regenix Group plc Appointment of CEO Steve Couldwell appointed Group CEO Leeds, 02 November 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces the appointment of Steve Couldwell, as Chief Executive Off...

Directorate Change

RNS Number: 8786T Tissue Regenix Group PLC 18 October 2017 [This announcement contains inside information.] Tissue Regenix Group plc Directorate Change Leeds, 18 October 2017 - The Board of Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group") today announces that Antony Odell, Chief Executive Officer (CEO), will be stepping down fro...

Fundamental DataMore

EPS-1.27
Dividend yield0 %

Latest discussion posts More

  • What are the chances...

    ...of an update ? Last meaningful informative operational news were the unaudited Interims back in September, last year ! Who is the new CFO? how is the assimilation of ...
    18-Jan-2018
    theprior
  • Re: The patient

    Rising sp continues apace. +4% so far today. Happy new year ! we?ll have to wait till next year to see what?s causing this renewed interest. But, hey, that?s only next week ...
    29-Dec-2017
    theprior
  • Re: The patient

    Positively glowing now almost +50% from its recent low !
    21-Dec-2017
    theprior

Users' HoldingsMore

Users who hold Tissue Regenix Group also hold..

Codes & Symbols

ISINGB00B5SGVL29
SymbolsTRX, LSE:TRX, TRX.L, TRX:LN, LON:TRX, XLON:TRX

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account